Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

Cephalon expands marketing coverage of Provigil to Latin America and Asia

March 24, 2000

Neurotrophic and cognition-enhancing effects reported for TEI-3356 this week in Yokohama

March 24, 2000

Sigma1-receptor confirmed as site of action for antipsychotic MS-377

March 24, 2000

SB reveals more novel anticonvulsants with affinity for novel binding site

March 24, 2000

U.K. virtual drug development company adds another product to its pipeline

March 24, 2000

Abbott and NPS establish agreement for NPS-1776

March 24, 2000

Merck compound L-754030 and use in circadian rhythm disorders covered by new patent

March 23, 2000

Abeta peptide formation inhibitors from Roche for the treatment of AD

March 23, 2000

Novel lactams prepared at DuPont inhibit Abeta-peptide production

March 22, 2000

Known antiallergic agent from Kyorin now claimed for use in MS

March 22, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 12, 2026.
Ethyreal launches to treat the underlying cause of Graves’, TED
BioWorld
Ethyreal Bio Inc. has come out of stealth mode in order to disclose preclinical data for ETHY-001, its monoclonal antibody targeting thyroid stimulating hormone...
Europe’s Alzecure, Orionis in $1B+ deals with Lilly, Novartis
BioWorld
Two companies with European ties signed billion-dollar deals with large pharma firms in the last two days to discover and develop molecular glue drugs, as well as...
Sanofi phase III CIDP quit dents Dianthus; C1 mismatch?
BioWorld
Investors in Dianthus Therapeutics Inc. apparently chose to ignore subtleties in the difference between efforts with that firm’s claseprubart vs. those by...
Microbiota modulates the antidepressant effects of GLP-1 analogues
BioWorld Science
Liraglutide, a glucagon-like peptide 1 (GLP-1) receptor agonist used in diabetes and obesity, could alleviate depression through a pathway that does not depend on...